T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Eldorado Gold
EGO
$10.2B
| $40.8M | 0.01% |
1,334,332
+322,378
| +32% | +$10.4M |
|
902
Visteon
VC
$2.82B
| $40.6M | 0.01% |
379,990
-466,660
| -55% | -$45M |
|
|
LO
903
DELISTED
LORILLARD INC COM STK
LO
| $40.6M | 0.01% |
644,400
+20,320
| +3% | +$1.26M |
|
|
OREX
904
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $40.4M | 0.01% |
666,520
-148,000
| -18% | -$7.43M |
|
905
National Bank Holdings
NBHC
$1.93B
| $40.4M | 0.01% |
2,079,310
+882,680
| +74% | +$17M |
|
906
Manitowoc
MTW
$728M
| $40.2M | 0.01% |
2,008,920
+76,725
| +4% | +$1.39M |
|
|
CSS
907
DELISTED
CSS Industries, Inc.
CSS
| $40.1M | 0.01% |
1,449,510
-11,900
| -0.8% | -$338K |
|
|
CLC
908
DELISTED
Clarcor
CLC
| $40M | 0.01% |
600,747
+14,427
| +2% | +$936K |
|
|
PRO
909
DELISTED
PROS Holdings
PRO
| $40M | 0.01% |
1,454,600
+104,940
| +8% | +$2.78M |
|
|
ICPT
910
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $40M | 0.01% |
256,202
-6,384
| -2% | -$1.18M |
|
911
Haverty Furniture Companies
HVT
$449M
| $39.9M | 0.01% |
1,811,820
-24,700
| -1% | -$530K |
|
|
PNRA
912
DELISTED
Panera Bread Co
PNRA
| $39.8M | 0.01% |
227,850
-243,574
| -52% | -$40.6M |
|
913
Devon Energy
DVN
$48.5B
| $39.7M | 0.01% |
648,154
+25,280
| +4% | +$1.53M |
|
|
CHK
914
DELISTED
Chesapeake Energy Corporation
CHK
| $39.6M | 0.01% |
10,116
-133,872
| -93% | -$556M |
|
|
LLTC
915
DELISTED
Linear Technology Corp
LLTC
| $39.5M | 0.01% |
865,300
+9,520
| +1% | +$414K |
|
916
Itaú Unibanco
ITUB
$81.3B
| $39.4M | 0.01% |
7,557,717
+1,837,879
| +32% | +$10.3M |
|
|
CSLT
917
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $39.4M | 0.01% |
3,368,170
-148,087
| -4% | -$1.77M |
|
|
HAYN
918
DELISTED
Haynes International, Inc.
HAYN
| $39.4M | 0.01% |
811,648
-125,350
| -13% | -$5.71M |
|
919
Saia
SAIA
$10B
| $39.3M | 0.01% |
709,980
+4,700
| +0.7% | +$245K |
|
|
TDAY
920
USA Today Co
TDAY
$1.01B
| $38.6M | 0.01% |
1,635,476
+353,371
| +28% | +$6.96M |
|
921
Employers Holdings
EIG
$873M
| $38.6M | 0.01% |
1,643,020
-15,900
| -1% | -$331K |
|
|
SASR
922
DELISTED
Sandy Spring Bancorp Inc
SASR
| $38.5M | 0.01% |
1,477,630
-3,850
| -0.3% | -$93.9K |
|
|
INVN
923
DELISTED
Invensense Inc
INVN
| $38.4M | 0.01% |
2,363,793
+774,843
| +49% | +$13M |
|
|
FRED
924
DELISTED
Fred's Inc
FRED
| $38.4M | 0.01% |
2,204,324
+174,420
| +9% | +$2.7M |
|
925
Azenta
AZTA
$1.48B
| $38.3M | 0.01% |
3,007,104
-25,700
| -0.8% | -$299K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.